Tempest Therapeutics, Inc. Payments to Acquire Short-term Investments
Tempest Therapeutics, Inc. (TPST) reported Payments to Acquire Short-term Investments of $33.49 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2018-11-09
- Tempest Therapeutics, Inc. payments to acquire short-term investments for the quarter ending 2018-09-30 was $6.83M, a 38.60% increase year-over-year.
- Tempest Therapeutics, Inc. payments to acquire short-term investments for the quarter ending 2018-06-30 was $10.42M, a 38.42% decline year-over-year.
- Tempest Therapeutics, Inc. payments to acquire short-term investments for the quarter ending 2018-03-31 was $16.25M, a 38.84% decline year-over-year.
- Tempest Therapeutics, Inc. payments to acquire short-term investments for the quarter ending 2017-12-31 was $20.45M, a 20.05% increase year-over-year.
- Tempest Therapeutics, Inc. payments to acquire short-term investments for fiscal 2017 was $68.86M, a 16.71% decline from fiscal 2016.
- Tempest Therapeutics, Inc. payments to acquire short-term investments for fiscal 2016 was $82.67M, a 13.18% decline from fiscal 2015.
- Tempest Therapeutics, Inc. payments to acquire short-term investments for fiscal 2015 was $95.22M, a 65.31% increase from fiscal 2014.
- Tempest Therapeutics, Inc. payments to acquire short-term investments for fiscal 2014 was $57.60M, a 260.60% increase from fiscal 2013.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month | Payments to Acquire Short-term Investments 21 month | Payments to Acquire Short-term Investments 24 month | Payments to Acquire Short-term Investments 27 month | Payments to Acquire Short-term Investments 30 month | Payments to Acquire Short-term Investments 33 month | Payments to Acquire Short-term Investments 36 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2018-09-30 | $6.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $17.25M derived: sum of 2 quarters · filed 2018-11-09 | $33.49M 10-Q · filed 2018-11-09 | $53.95M derived: sum of 4 quarters · filed 2018-11-09 | ||||||
| 2018-06-30 | $10.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $26.66M 10-Q · filed 2018-08-09 | $47.12M derived: sum of 3 quarters · filed 2018-08-09 | $52.04M derived: sum of 4 quarters · filed 2018-11-09 | ||||||
| 2018-03-31 | $16.25M 10-Q · filed 2018-05-03 | $36.70M derived: sum of 2 quarters · filed 2018-05-03 | $41.63M derived: sum of 3 quarters · filed 2018-11-09 | $58.54M derived: sum of 4 quarters · filed 2018-11-09 | ||||||
| 2017-12-31 | $20.45M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $25.38M derived: sum of 2 quarters · filed 2018-11-09 | $42.30M derived: sum of 3 quarters · filed 2018-11-09 | $68.86M 10-K · filed 2018-03-15 | ||||||
| 2017-09-30 | $4.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $21.84M derived: sum of 2 quarters · filed 2018-11-09 | $48.40M 10-Q · filed 2018-11-09 | $65.44M derived: sum of 4 quarters · filed 2018-11-09 | ||||||
| 2017-06-30 | $16.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $43.48M 10-Q · filed 2018-08-09 | $60.51M derived: sum of 3 quarters · filed 2018-08-09 | $99.00M derived: sum of 4 quarters · filed 2018-08-09 | ||||||
| 2017-03-31 | $26.56M 10-Q · filed 2018-05-03 | $43.60M derived: sum of 2 quarters · filed 2018-05-03 | $82.09M derived: sum of 3 quarters · filed 2018-05-03 | $82.11M derived: sum of 4 quarters · filed 2018-05-03 | ||||||
| 2016-12-31 | $17.04M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $55.53M derived: sum of 2 quarters · filed 2018-03-15 | $55.55M derived: sum of 3 quarters · filed 2018-03-15 | $82.67M 10-K · filed 2018-03-15 | ||||||
| 2016-09-30 | $38.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $38.52M derived: sum of 2 quarters · filed 2017-11-02 | $65.63M 10-Q · filed 2017-11-02 | $78.79M derived: sum of 4 quarters · filed 2018-03-15 | ||||||
| 2016-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $27.14M 10-Q · filed 2017-08-03 | $40.30M derived: sum of 3 quarters · filed 2018-03-15 | $53.45M derived: sum of 4 quarters · filed 2018-03-15 | ||||||
| 2016-03-31 | $27.12M 10-Q · filed 2017-05-09 | $40.27M derived: sum of 2 quarters · filed 2018-03-15 | $53.42M derived: sum of 3 quarters · filed 2018-03-15 | $122.34M derived: sum of 4 quarters · filed 2018-03-15 | ||||||
| 2015-12-31 | $13.15M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $26.31M derived: sum of 2 quarters · filed 2018-03-15 | $95.22M derived: sum of 3 quarters · filed 2018-03-15 | $95.22M 10-K · filed 2018-03-15 | ||||||
| 2015-09-30 | $13.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $82.07M derived: sum of 2 quarters · filed 2016-11-03 | $82.07M 10-Q · filed 2016-11-03 | $82.07M derived: sum of 4 quarters · filed 2017-03-02 | ||||||
| 2015-06-30 | $68.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $68.92M 10-Q · filed 2016-08-04 | $68.92M derived: sum of 3 quarters · filed 2017-03-02 | $68.92M derived: sum of 4 quarters · filed 2017-03-02 | ||||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-05 | $0.00 derived: sum of 2 quarters · filed 2017-03-02 | -$1.00K derived: sum of 3 quarters · filed 2017-03-02 | $41.33M derived: sum of 4 quarters · filed 2017-03-02 | ||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | -$1.00K derived: sum of 2 quarters · filed 2017-03-02 | $41.33M derived: sum of 3 quarters · filed 2017-03-02 | $57.60M 10-K · filed 2017-03-02 | ||||||
| 2014-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $41.33M derived: sum of 2 quarters · filed 2015-11-05 | $57.60M 10-Q · filed 2015-11-05 | $57.60M derived: sum of 4 quarters · filed 2016-02-26 | ||||||
| 2014-06-30 | $41.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $57.60M 10-Q · filed 2015-08-10 | $57.60M derived: sum of 3 quarters · filed 2016-02-26 | $62.80M derived: sum of 4 quarters · filed 2016-02-26 | ||||||
| 2014-03-31 | $16.27M 10-Q · filed 2015-05-11 | $16.27M derived: sum of 2 quarters · filed 2016-02-26 | $21.46M derived: sum of 3 quarters · filed 2016-02-26 | $32.25M derived: sum of 4 quarters · filed 2016-02-26 | $48.95M 10-Q · filed 2014-05-08 | |||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $5.19M derived: sum of 2 quarters · filed 2016-02-26 | $15.97M derived: sum of 3 quarters · filed 2016-02-26 | $15.97M 10-K · filed 2016-02-26 | $32.67M 10-K · filed 2014-02-27 | |||||
| 2013-09-30 | $5.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $15.97M derived: sum of 2 quarters · filed 2014-11-10 | $15.97M 10-Q · filed 2014-11-10 | $32.67M 10-Q · filed 2013-11-13 | ||||||
| 2013-06-30 | $10.78M derived: 10-Q 27 month − 10-Q 24 month · filed 2013-08-13 | $10.78M 10-Q · filed 2014-08-07 | $27.48M 10-Q · filed 2013-08-13 | |||||||
| 2013-03-31 | $0.00 derived: 10-Q 24 month − 10-K 21 month · filed 2013-05-15 | $16.70M 10-Q · filed 2013-05-15 | ||||||||
| 2012-12-31 | $16.70M 10-K · filed 2015-03-16 | $16.70M 10-K · filed 2013-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |